The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.

about

The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.

Item

http://www.wikidata.org/entity/Q35590977

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

The impact of antiviral therap ...... come of chronic HCV infection.

@ast

The impact of antiviral therap ...... come of chronic HCV infection.

@en

type

Item

label

The impact of antiviral therap ...... come of chronic HCV infection.

@ast

The impact of antiviral therap ...... come of chronic HCV infection.

@en

prefLabel

The impact of antiviral therap ...... come of chronic HCV infection.

@ast

The impact of antiviral therap ...... come of chronic HCV infection.

@en

P1476

The impact of antiviral therap ...... come of chronic HCV infection.

@en

P2093

Andrea Costantino

http://www.w3.org/2001/XMLSchema#string

Marcello Persico

http://www.w3.org/2001/XMLSchema#string

Marta Mazza

http://www.w3.org/2001/XMLSchema#string

Piero Luigi Almasio

http://www.w3.org/2001/XMLSchema#string

Savino Bruno

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

P304

314301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4061/2011/314301

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51873811

http://www.w3.org/2001/XMLSchema#string

P698

22164334

http://www.w3.org/2001/XMLSchema#string

P932

3230116

http://www.w3.org/2001/XMLSchema#string